Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Hum Immunol. 2021 Apr 17;82(8):593–599. doi: 10.1016/j.humimm.2021.04.001

Table 3:

Association of AD and HLA Class I allelic variation presented as odds ratios with 95% confidence intervals (OR > 1 represents increased risk). ORs presented for the full cohort. The full cohort adjusted by ancestry and for just those of European or African ancestry. The p-value correction (in manuscript) is based on analyses per gene; HLA-A 4, HLA-B 6 and HLA-C 6.

Allele OR p-value Adjusted OR European Ancestry African Ancestry
A*01:01 0.46 (0.33, 0.63) 1.35e-06 0.55(0.40, 0.77) 0.54 (0.37, 0.77) 0.54(0.22, 1.35)
A*02:01 0.71 (0.56, 0.90) .0049846 0.82(0.63, 1.06) 0.94 (0.70, 1.24) 0.64(0.38, 1.11)
A*03:01 0.92 (0.70, 1.21) .5642952 1.05(0.79, 1.41) 0.94 (0.67, 1.31) 1.31(0.76, 2.26)
A*24:02 0.75 (0.51, 1.20) .1549402 0.89(0.59, 1.34) 1.09 (0.70, 1.71) 0.13(0.04, 0.47)
B*07:02 0.60 (0.43, 0.82) .0015001 0.56(0.40, 0.78) 0.48 (0.31, 0.75) 0.77(0.44, 1.34)
B*08:01 0.84 (0.59, 1.20) .3335906 1.03(0.71, 1.50) 1.02 (0.68, 1.52) 1.03(0.43, 2.46)
B*35:01 0.88 (0.59, 1.34) .5634918 0.88(0.57, 1.35) 0.62 (0.34, 1.12) 1.36(0.70, 2.66)
B*44:02 0.83 (0.57, 1.23) .3660473 1.06(0.71, 1.60) 1.10 (0.71, 1.69) 0.77(0.28, 2.13)
B*44:03 1.60 (1.00, 2.58) .0516518 1.62(0.99, 2.66) 1.52 (0.82, 2.81) 2.06(0.92, 4.63)
B*53:01 1.98 (1.22, 3.22) .005361 1.43(0.87, 2.36) 1.77 (0.49, 6.36) 1.51(0.88, 2.60)
C*03:04 1.31 (0.87, 1.98) .1919211 1.23(0.80, 1.90) 1.35 (0.77, 2.36) 1.10(0.57, 2.11)
C*04:01 1.17 (0.89, 1.54) .2586665 1.12(0.84, 1.50) 0.80 (0.55, 1.16) 2.10(1.28, 3.42)
C*05:01 0.77 (0.52, 1.13) .1841949 0.97(0.64, 1.45) 0.92 (0.59, 1.43) 0.97(0.37, 2.54)
C*06:02 0.60 (0.41, 0.89) .0109947 0.66(0.44, 0.98) 0.66 (0.41, 1.06) 0.80(0.38, 1.69)
C*07:01 0.89 (0.67, 1.18) .4195639 1.06(0.78, 1.42) 1.06 (0.76, 1.47) 1.00(0.53, 1.88)
C*07:02 0.66 (0.49, 0.90) .0084513 0.66(0.48, 0.91) 0.58 (0.39, 0.86) 0.88(0.48, 1.60)